Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
RPH3AL |
rabphilin 3A-like (without C2 domains) |
17p13.3 |
rSNP target |
0
|
IEA
|
OXTR |
oxytocin receptor |
3p25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
LTA |
lymphotoxin alpha |
6p21.3 |
Mapped by Literature SNP |
0
|
IEA
|
BLMH |
bleomycin hydrolase |
17q11.2 |
Mapped by LD-proxy |
0
|
IEA
|
TRPA1 |
transient receptor potential cation channel, subfamily A, member 1 |
8q13 |
rSNP target |
0
|
IEA
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(11/10/0)
|
IEA
|
CDK1 |
cyclin-dependent kinase 1 |
10q21.2 |
rSNP target |
0
|
IEA
|
BDNF |
brain-derived neurotrophic factor |
11p14.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
19(4/15/0)
|
IEA
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
44(13/31/0)
|
IEA
|
RAD54L |
RAD54-like (S. cerevisiae) |
1p32 |
rSNP target |
0
|
IEA
|
IFNG |
interferon, gamma |
12q14 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IEA
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
PTK2B |
protein tyrosine kinase 2 beta |
8p21.1 |
Mapped by LD-proxy |
0
|
IEA
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
ISS
|
ADCYAP1R1 |
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
19(8/11/0)
|
IEA
|
ACTC1 |
actin, alpha, cardiac muscle 1 |
15q14 |
rSNP target |
0
|
IEA
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(9/12/0)
|
IEA
|
ABCC1 |
ATP binding cassette subfamily C member 1 |
16p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS[1360704]
|
APOA1 |
apolipoprotein A-I |
11q23-q24 |
Mapped by LD-proxy |
0
|
IEA
|
CHRNA3 |
cholinergic receptor, nicotinic alpha 3 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
IEA
|
MAOB |
monoamine oxidase B |
Xp11.4-p11.3 |
Literature-origin, Mapped by Literature SNP |
3(1/2/0)
|
IEA
|
DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
IBA; ISS
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
IDA[15862800|18703043]
|
SRD5A2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
2p23.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
11(11/0/0)
|
IEA
|
CAT |
catalase |
11p13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|